Navigation Links
Study to evaluate zoning code reforms and physical activity
Date:8/21/2012

Researchers at the University of Illinois at Chicago have received a $1.5 million federal grant to examine the relationship between zoning code reforms, the physical environment, and physical-activity behavior in communities throughout the U.S.

The study, funded by National Institutes of Health, is one of the first to look at community-level land use nationwide to see how zoning can facilitate or inhibit structural change in the environment that could lead to increased physical activity among adults, says principal investigator Jamie Chriqui, senior research scientist at UIC's Institute for Health Research and Policy.

Communities are increasingly using zoning and land-use laws to reform the physical environment. Many zoning reforms of the past decade were aimed at increasing active living through a mix of residential, commercial, retail and recreational areas interconnected by biking, walking, and public transportation.

The reforms have been adopted by communities in at least 35 states as a way to rely less on automobile transportation, reduce sprawl, and increase physical activity, according to the researchers.

But Chriqui says little is known about "whether or not these zoning reforms are being implemented in communities -- through structural changes to the environment such as sidewalks, parks and trails, bike paths, and street connectivity -- and ultimately, whether or not these changes are increasing physical activity levels within communities."

The researchers will compile zoning codes for municipalities and counties encompassing more than half of the U.S. population. Data will be aggregated at the county level, to correlate with county-level physical activity measures.

"We have developed evaluation tools to measure the strength and comprehensiveness of community-level zoning using markers for walkability, bikability, active and passive recreation, bicycle and trails, and interconnected street activity,
'/>"/>

Contact: Sherri McGinnis Gonzlez
smcginn@uic.edu
312-996-8277
University of Illinois at Chicago
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... NY (PRWEB) March 05, 2015 Shania Twain ... in more than a decade. She has hinted that this ... to miss seeing her perform one last time. She has ... and this beloved country sweetheart has millions of loyal fans around ... throughout her native country, Canada, and on June 30th she will ...
(Date:3/5/2015)... 2015 This week, 60 ... low-cost laminate flooring products, initiating widespread concern from ... building materials made primarily from bamboo, stands behind ... their flooring products for volatile organic compounds (VOCs) ... International (BMH). Results from formaldehyde emissions testing ...
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned ... awarding the plaintiff Coleen M. Perry a total of $5.7 ... TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, Inc., a ... a partner at Wagstaff & Cartmell in Kansas ... along with Rich Freese and Tim Goss of Freese ...
(Date:3/5/2015)... 05, 2015 AxoGen, Inc. (NASDAQ: ... the peripheral nerve repair market, reported record revenue of ... 2014 compared to $2.98 million in the year-ago fourth ... strategies. , “Our strong fourth quarter revenue growth ... repair products which is driving increased surgeon adoption of ...
(Date:3/5/2015)... March 05, 2015 Risperdal lawsuits ... a Pennsylvania mass tort litigation currently underway in ... jury has begun hearing testimony in the proceeding’s ... antipsychotic medication can cause gynecomastia, or male breast ... question was filed on behalf of a plaintiff ...
Breaking Medicine News(10 mins):Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3
... CEO, Will Continue Serving as Chairman of the Board, ... Bulletin Board: MLSS), the recognized leader in,advanced injection technologies, ... Martin, Chief Executive Officer of the Company,s,medical division, as ... of its Board,of Directors, effective January 1, 2008. As ...
... Detection and treatment of tumours, diseased blood vessels and ... an innovative imaging system being developed that uses both ... extremely short pulses of low-energy laser light to stimulate ... area being examined. These waves are then converted into ...
... Amsterdam, December 12, 2007 Elsevier, a leading ... today announced that 45 French-language medical journals from ... January 3, 2008. , The titles, including Feuillets ... Mdicale, represent a wide range of high-quality journals ...
... by 81 percent of Michigan adults, DETROIT, Dec. ... of reform measures proposed in the Michigan Legislature,that would ... increases and set standard rating practices for all insurers ... made public today,by Blue Cross Blue Shield of Michigan., ...
... TITUSVILLE, N.J., Dec. 12 INVEGA(TM) (paliperidone),Extended-Release ... a one-year open-label extension (OLE) study, according ... symptom scores improved or,were stable, on average, ... was designed to evaluate the long-term safety ...
... it. Hair Fairies - The Head Lice, Helpers - is here to ... ... No two words in the English language,can stop every parent in ... other kid-centric services are often,sent into crisis mode when an outbreak occurs, ...
Cached Medicine News:Health News:Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors 2Health News:Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors 3Health News:Light and sound -- the way forward for better medical imaging 2Health News:ScienceDirect to host French-language journals from Elsevier Masson 2Health News:Overwhelming Majority of Michigan Residents Favors Individual Health Insurance Market Reforms Supported by Blue Cross Blue Shield of Michigan 2Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 2Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 3Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 4Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 5Health News:INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia 6Health News:Head Lice Removal Service Opens in Chicago 2Health News:Head Lice Removal Service Opens in Chicago 3
(Date:3/5/2015)... , March 5, 2015   MeridianRx ... and met all seven optional leading indicators during ... Management. "We are very proud of ... Rene Acker , Chief Operating Officer of ... dedication and commitment to transparency, flexibility and innovation." ...
(Date:3/5/2015)... 5, 2015 BioLineRx (NASDAQ: ... dedicated to identifying, in-licensing and developing promising therapeutic ... underwritten public offering of American Depositary Shares ("ADSs"), ... All of the ADSs in the offering are ... JMP Securities is acting as sole book-running manager ...
(Date:3/5/2015)... DIEGO , March 5, 2015  Pfenex ... engaged in the development of biosimilar therapeutics including ... today that its fourth quarter and full year ... March 16, 2015, before the market opens for ... will host a conference call to discuss the ...
Breaking Medicine Technology:MeridianRx Earns Highest URAC Accreditation Status 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2
... Boehringer Ingelheim and Eli Lilly and Company ... they have received a positive opinion from the ... of Jentadueto® (linagliptin/metformin hydrochloride) tablets, a medicine combining ... Tradjenta® tablets, marketed under the trade name Trajenta® ...
... Ohio, May 29, 2012  Rittal Corp. today announced it ... Architecture (PIA) Alliance, selected by HP for its server ... that contribute to the industry-transforming performance and reliability of ... ProActive Insight Architecture, now available in the new HP ...
Cached Medicine Technology:Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe 2Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe 3Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe 4Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe 5Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe 6Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe 7Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe 8Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe 9Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe 10Rittal Corp. Joins the HP ProActive Insight Architecture Alliance 2
... fixed-volume, adjustable-volume, and multichannel models as ... pro Pipette. Designed with a separate ... have earned a worldwide reputation for ... original Eppendorf pipette tips, they provide ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Research Family includes fixed-volume, adjustable-volume, and ... electronic Eppendorf Research pro Pipette. Designed ... compact, high-performance pipettes have earned a ... for use with original Eppendorf pipette ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: